Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2010
03/31/2010CN101687925A engineered anti-il-23p19 antibodies
03/31/2010CN101687869A Heterocyclic compounds useful as MK2 inhibitors
03/31/2010CN101687867A imidazoquinolines with immuno-modulating properties
03/31/2010CN101687854A Compounds and compositions as C-KIT and PDGFR kinase inhibitors
03/31/2010CN101687850A Substituted pyrimidines as adenosine receptor antagonists
03/31/2010CN101687842A modulators of cftr
03/31/2010CN101687838A Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity
03/31/2010CN101687819A Novel preparation for external use
03/31/2010CN101687807A 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof
03/31/2010CN101687019A Medicaments and methods to treat autoimmune disease and cancer
03/31/2010CN101687017A Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
03/31/2010CN101684445A Deer horn blood wine and processing method thereof
03/31/2010CN101684158A Binding domain-immunoglobulin fusion proteins
03/31/2010CN101684156A Human TNF alpha monoclonal antibody, PEGylation nanoparticle and application thereof
03/31/2010CN101684097A Phenylpyrimidine amines as ige inhibitors
03/31/2010CN101684091A cannabinoid receptor ligands
03/31/2010CN101683519A Composition of thymic peptide alpha 1 and thymopeptide-5 and preparation method thereof
03/31/2010CN101683427A Traditional Chinese medicine composition and preparation method thereof
03/31/2010CN101683379A Novel health care capsule formula
03/31/2010CN101683343A Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury
03/31/2010CN101683334A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
03/31/2010CN101683310A Anthranilic acid amides and the derivatives thereof as cosmetic and pharmaceutical agents
03/31/2010CN100596282C Liuweidihuang multiple vatimines and its preparing method
03/30/2010US7687664 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it
03/30/2010US7687637 5-phenylthiazole derivatives and use as Pi3 kinase inhibitors
03/30/2010US7687607 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLS)
03/30/2010US7687606 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil.
03/30/2010US7687507 Protein tyrosine kinase, such as Janus Kinase 3, inhibitors, immunosuppressants; organ transplants, lupus, multiple sclerosis, psoriasis; antidiabetic agents, antiarthritic agents, anticarcinogenic agents, Alzheimer's Disease, Crohn's Disease, Inflammatory Bowel Disease, autoimmune thyroid disorders
03/30/2010US7687505 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
03/30/2010US7687059 Systems and methods for treating patients with processed lipoaspirate cells
03/30/2010CA2420894C Thienopyrimidines
03/30/2010CA2372633C Staphylococcus aureus antigen-containing whole cell vaccine
03/30/2010CA2355860C Dosage forms comprising porous particles
03/30/2010CA2170523C Cloned glutamic acid decarboxylase
03/30/2010CA2144223C Effector proteins of rapamycin
03/25/2010WO2010033736A1 Novel compositons and methods for treating ige-mediated disorders
03/25/2010WO2010032123A1 Triterpenoid compounds and methods of use thereof
03/25/2010WO2010031744A1 Whey and thymus function
03/25/2010WO2010031519A1 Transcutaneous compositions for specific immuno-modulatory treatment
03/25/2010WO2010031251A1 Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof
03/25/2010WO2010008733A3 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use
03/25/2010WO2010006123A3 19-nor-vitamin d analogs with 1,2-dihydrofuran ring
03/25/2010WO2010006121A3 19-nor-vitamin d analogs with 3,2-dihydrofuran ring
03/25/2010WO2009151496A3 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells
03/25/2010WO2009111998A3 Specific impurities of montelukast
03/25/2010US20100076088 Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it
03/25/2010US20100076068 Aminoalcohol Derivatives and Their Therapeutic Use
03/25/2010US20100076060 Aptamers as agonists
03/25/2010US20100076029 Compounds Which Selectively Modulate The CB2 Receptor
03/25/2010US20100076024 Novel Compounds as Serine Protease Inhibitors
03/25/2010US20100076014 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
03/25/2010US20100076008 Pharmaceutical compositions containing plasma protein
03/25/2010US20100075997 Use of pkc inhibitors in transplantation
03/25/2010US20100075996 Pyrrolo[2,3-d]pyrimidine compounds
03/25/2010US20100075990 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
03/25/2010US20100075975 Medicament for the enhancement of cognitive function and neuroprotection
03/25/2010US20100075961 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
03/25/2010US20100075946 Novel thiophene derivatives
03/25/2010US20100075936 Use of glucocorticoid receptor antagonists for treatment of infectious conditions
03/25/2010US20100074922 Pneumococcal polysaccharide conjugate vaccine
03/25/2010US20100074921 Carrier
03/25/2010US20100074920 Peptide vaccine for influenza virus
03/25/2010US20100074918 Vaccine
03/25/2010US20100074913 Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
03/25/2010US20100074905 Methods for soluble zalpha11 cytokine receptors
03/25/2010US20100074904 Specific activation of a regulatory t cell and its use for treatment of asthma, allergic disease, autoimmune disease, graft rejection and for tolerance induction
03/25/2010US20100074903 Novel antibody formulation
03/25/2010US20100074902 Methods for human allografting
03/25/2010US20100074900 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
03/25/2010US20100074878 Probiotic bacterium: lactobacillus fermentum
03/25/2010US20100074871 Probiotic infant products
03/25/2010US20100074869 Multifunctional Cytokines
03/25/2010US20100074865 Formulations of peg-interferon alpha conjugates
03/25/2010US20100074864 Methods and kits for predicting prognosis of multiple sclerosis
03/25/2010CA2737771A1 Whey and thymus function
03/25/2010CA2737619A1 Nutritional support of the immune system during anti-cancer treatment
03/25/2010CA2737355A1 Rapalogs, pharmaceutical compositions, preparation methods and uses thereof
03/25/2010CA2737212A1 Dendritic cell modulatory molecule
03/25/2010CA2736774A1 Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor
03/25/2010CA2736747A1 Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment
03/25/2010CA2736511A1 Novel compositions and methods for treating ige-mediated disorders
03/25/2010CA2725381A1 Nanoemulsion adjuvants
03/24/2010EP2165713A1 Whey and thymus function
03/24/2010EP2164874A1 Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity
03/24/2010EP2164850A2 N-substituted azaindoles and methods of use
03/24/2010EP2164840A2 Modulators of cftr
03/24/2010EP2164828A2 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation
03/24/2010EP2164507A1 Treatment of allergic disease with immunomodulator compounds
03/24/2010EP2164502A1 Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis
03/24/2010EP2164498A1 Pregnancy hormone combination for treatment of autoimmune diseases
03/24/2010EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/24/2010EP1328511B1 Substituted (e)-styryl benzylsulfones for treating proliferative disorders
03/24/2010EP1075496B1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
03/24/2010EP1067962B1 Derivatives of pneumococcal choline binding proteins for vaccines
03/24/2010CN201426435Y Pine needle health-care shoe pad
03/24/2010CN101679528A Apoptotic anti-ige antibodies
03/24/2010CN101679526A Humanized and chimeric anti-TROP-2 antibodies that mediate cancer cell cytotoxicity
03/24/2010CN101679519A Antibodies to CD200R
03/24/2010CN101679517A Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
03/24/2010CN101679470A Method for production of sugar oxazoline derivative
1 ... 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 ... 1172